{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:22:03Z","timestamp":1783531323591,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KUN 2013-5926"],"award-info":[{"award-number":["KUN 2013-5926"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["2017-2\/11179"],"award-info":[{"award-number":["2017-2\/11179"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["91717334"],"award-info":[{"award-number":["91717334"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018377","name":"Medisch Spectrum Twente","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clgc.2025.102464","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:45:27Z","timestamp":1762307127000},"page":"102464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recurrence Patterns in a Large Contemporary Cohort of Patients With Non-Muscle Invasive Bladder Cancer"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7461-6364","authenticated-orcid":false,"given":"Jasper P.","family":"Hof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-1326","authenticated-orcid":false,"given":"Lambertus A.L.M.","family":"Kiemeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-2147","authenticated-orcid":false,"given":"Katja K.H.","family":"Aben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8839-8601","authenticated-orcid":false,"given":"Antoine G.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-2125","authenticated-orcid":false,"given":"Alina","family":"Vrieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4913-8601","authenticated-orcid":false,"given":"Sita H.","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6 Suppl 1","key":"10.1016\/j.clgc.2025.102464_bib0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.clgc.2025.102464_bib0002","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1007\/s00345-020-03569-2","article-title":"Follow-up in non-muscle invasive bladder cancer: facts and future","volume":"39","author":"Witjes","year":"2021","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102464_bib0003","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102464_bib0004","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","article-title":"Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy","volume":"56","author":"van Rhijn","year":"2009","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102464_bib0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) Prognostic Factor Risk Groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 Classification systems for grade: an update from the EAU NMIBC Guidelines Panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102464_bib0006","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102464_bib0007","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.eururo.2011.07.010","article-title":"Smoking status is a risk factor for recurrence after transurethral resection of non\u2013Muscle-invasive bladder cancer","volume":"60","author":"Lammers","year":"2011","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102464_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229384","article-title":"No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression","volume":"15","author":"Evers","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clgc.2025.102464_bib0009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/BLC-190249","article-title":"Lifestyle and non-muscle invasive bladder cancer recurrence, progression, and mortality: available research and future directions","volume":"6","author":"Zuniga","year":"2020","journal-title":"Bladder Cancer."},{"issue":"4","key":"10.1016\/j.clgc.2025.102464_bib0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/cncr.33300","article-title":"Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle-invasive bladder cancer in a multisite, community-based cohort","volume":"127","author":"Garg","year":"2021","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.clgc.2025.102464_bib0011","first-page":"3681","article-title":"Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection","volume":"125","author":"Deng","year":"2012","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"10.1016\/j.clgc.2025.102464_bib0012","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.euf.2017.09.002","article-title":"Discrepancy between European Association of urology guidelines and daily practice in the management of non\u2013muscle-invasive bladder cancer: results of a European survey","volume":"5","author":"Hendricksen","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"2","key":"10.1016\/j.clgc.2025.102464_bib0013","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.clgc.2019.10.005","article-title":"Impact of bladder neck involvement on recurrence in patients with non-muscle-invasive bladder cancer: an analysis based on a time-dependent model","volume":"18","author":"Waseda","year":"2020","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"10.1016\/j.clgc.2025.102464_bib0014","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/aje\/kwx133","article-title":"Prediction of multiple recurrent events: a comparison of extended cox models in bladder cancer","volume":"186","author":"Smedinga","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102464_bib0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1308\/003588410X12664192076935","article-title":"Mechanisms of recurrence of Ta\/T1 bladder cancer","volume":"92","author":"Bryan","year":"2010","journal-title":"Ann R Coll Surg Engl"},{"issue":"2","key":"10.1016\/j.clgc.2025.102464_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211721","article-title":"Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score","volume":"14","author":"Simon","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2025.102464_bib0017","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.urology.2022.12.009","article-title":"Natural history of multiple recurrences in intermediate-risk non-muscle invasive bladder cancer: lessons from a prospective cohort","volume":"173","author":"Sharma","year":"2023","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.clgc.2025.102464_bib0018","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/diagnostics11020185","article-title":"Photodynamic diagnosis-assisted transurethral resection using oral 5-aminolevulinic acid decreases the risk of repeated recurrence in non-muscle-invasive bladder cancer: a cumulative incidence analysis by the person-time method","volume":"11","author":"Miyake","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"10.1016\/j.clgc.2025.102464_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030396","article-title":"The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life","volume":"9","author":"de Goeij","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.clgc.2025.102464_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089164","article-title":"Prognostic relevance of urinary bladder cancer susceptibility loci","volume":"9","author":"Grotenhuis","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clgc.2025.102464_bib0021","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.euf.2017.08.007","article-title":"Gender-specific differences in recurrence of non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"4","author":"Uhlig","year":"2018","journal-title":"Eur Urol Focus"},{"issue":"3","key":"10.1016\/j.clgc.2025.102464_bib0022","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.juro.2006.10.048","article-title":"Pattern of recurrence changes in noninvasive bladder tumors observed during 2 decades","volume":"177","author":"Mariappan","year":"2007","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102464_bib0023","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/bju.16780","article-title":"Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study","volume":"136","author":"Longoni","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2025.102464_bib0024","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.urology.2024.07.017","article-title":"Low-grade urothelial carcinoma recurs at a tempo that naturally accelerates over time","volume":"193","author":"Sankin","year":"2024","journal-title":"Urology"},{"issue":"10","key":"10.1016\/j.clgc.2025.102464_bib0025","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.urolonc.2020.06.013","article-title":"Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: a systematic review","volume":"38","author":"Mori","year":"2020","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102464_bib0026","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000518166","article-title":"Discrepancy between German S3 guideline recommendations and daily urologic practice in the management of nonmuscle invasive bladder cancer: results of a binational survey","volume":"107","author":"Struck","year":"2023","journal-title":"Urologia Internationalis"},{"issue":"1","key":"10.1016\/j.clgc.2025.102464_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bju.16675","article-title":"Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancer","volume":"136","author":"Scilipoti","year":"2025","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.clgc.2025.102464_bib0028","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.eururo.2025.05.005","article-title":"Management dilemma for very high-risk non-muscle-invasive bladder cancer: real-world data challenge the guideline recommendation for upfront radical cystectomy","volume":"88","author":"Subiela","year":"2025","journal-title":"Eur Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:45:40Z","timestamp":1773863140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325001648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1558767325001648"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102464","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence Patterns in a Large Contemporary Cohort of Patients With Non-Muscle Invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102464"}}